Inventor · disambiguated record
Scott Duncan
Also filed as: DUNCAN SCOTT · DUNCAN SCOTT M · DUNCAN SCOTT MASON
46 granted patents·10 pending applications·320 citations·filing 1989–2024
98Inventor score
Files withALKERMES PHARMA IRELAND LTD20STEALTH BIOTHERAPEUTICS INC10STEALTH BIOTHERAPEUTICS CORP8WYETH CORP6CENTREXION THERAPEUTICS CORP3
Top patents by PatentIndex Score
56 records- 0198US9090558B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2014·Granted Jul 28, 2015·38 cites·2 claims
- 0298US8669281B1Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2013·Granted Mar 11, 2014·97 cites·4 claims
- 0397US11261213B2Crystalline bis- and tris-hydrochloride salt of elamipretideSTEALTH BIOTHERAPEUTICS INC·Filed 2020·Granted Mar 1, 2022·4 cites·4 claims
- 0497US11034724B2Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH2STEALTH BIOTHERAPEUTICS CORP·Filed 2018·Granted Jun 15, 2021·5 cites·14 claims
- 0595US11773136B2Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH2STEALTH BIOTHERAPEUTICS INC·Filed 2021·Granted Oct 3, 2023·2 cites·14 claims
- 0695US11555053B2Crystalline salt formsSTEALTH BIOTHERAPEUTICS INC·Filed 2020·Granted Jan 17, 2023·3 cites·8 claims
- 0793US10683326B2Crystalline salt formsSTEALTH BIOTHERAPEUTICS CORP·Filed 2017·Granted Jun 16, 2020·6 cites·15 claims
- 0893US10676506B2Crystalline bis- and tris-hydrochloride salt of elamipretideSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Granted Jun 9, 2020·6 cites·19 claims
- 0993US2025127747A1Prodrugs of Fumarates and Their Use in Treating Various DiseasesALKERMES PHARMA IRELAND LTD·Filed 2024·Application pending·0 cites
- 1092US11083703B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2020·Granted Aug 10, 2021·2 cites·4 claims
- 1192US9775823B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2016·Granted Oct 3, 2017·8 cites·12 claims
- 1292US9505776B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2014·Granted Nov 29, 2016·10 cites·8 claims
- 1391US10975118B2Crystalline dipeptides useful in the synthesis of elamipretideSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Granted Apr 13, 2021·4 cites·4 claims
- 1491US2025188122A1Crystalline salt forms of boc-d-arg-dmt-lys-(boc)-phe-nh2STEALTH BIO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1590US12076306B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2023·Granted Sep 3, 2024·0 cites·4 claims
- 1690US11560404B2Crystalline dipeptides useful in the synthesis of elamipretideSTEALTH BIOTHERAPEUTICS INC·Filed 2021·Granted Jan 24, 2023·1 cites·4 claims
- 1790US10596140B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2019·Granted Mar 24, 2020·4 cites·4 claims
- 1889US12110345B2Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH2STEALTH BIOTHERAPEUTICS INC·Filed 2023·Granted Oct 8, 2024·0 cites·18 claims
- 1989US7126025B2Synthesis of 4-(amino)-2-butenoyl chlorides and their use in the preparation of 3-cyano quinolinesWYETH CORP·Filed 2004·Granted Oct 24, 2006·25 cites·12 claims
- 2089US2025122238A1Crystalline dipeptides useful in the synthesis of elamipretideSTEALTH BIO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2188US10961273B2N-carboxyanhydride-based-scale synthesis of elamipretideSTEALTH BIOTHERAPEUTICS CORP·Filed 2017·Granted Mar 30, 2021·4 cites·20 claims
- 2288US2024300969A1Prodrugs of Fumarates and Their Use in Treating Various DiseasesALKERMES PHARMA IRELAND LTD·Filed 2024·Application pending·0 cites
- 2385US12018094B2Crystalline dipeptides useful in the synthesis of elamipretideSTEALTH BIOTHERAPEUTICS INC·Filed 2022·Granted Jun 25, 2024·0 cites·19 claims
- 2482US11447444B1Capsaicinoid prodrug compounds and their use in treating medical conditionsCENTREXION THERAPEUTICS CORP·Filed 2020·Granted Sep 20, 2022·1 cites·20 claims
- 2582USRE41084EAntineoplastic combinationsWYETH CORP·Filed 2006·Granted Jan 19, 2010·2 cites·35 claims
- 2681US11905298B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2021·Granted Feb 20, 2024·0 cites·2 claims
- 2781US11254659B1Capsaicinoid prodrug compounds and their use in treating medical conditionsCENTREXION THERAPEUTICS CORP·Filed 2020·Granted Feb 22, 2022·1 cites·20 claims
- 2881US10406133B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2018·Granted Sep 10, 2019·1 cites·4 claims
- 2981US2025002531A1Processes for preparing pharmaceutically relevant peptidesSTEALTH BIOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3080US12252553B2Crystalline salt formsSTEALTH BIOTHERAPEUTICS INC·Filed 2022·Granted Mar 18, 2025·0 cites·8 claims
- 3180US11679092B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2021·Granted Jun 20, 2023·0 cites·4 claims
- 3280US11325943B2Crystalline salt forms of SBT-20STEALTH BIOTHERAPEUTICS CORP·Filed 2018·Granted May 10, 2022·1 cites·14 claims
- 3379US5570013ASpeed sensor assembly having a fluid seal carrier and piloting cupTORRINGTON CO·Filed 1993·Granted Oct 29, 1996·40 cites·7 claims
- 3479US4875785AThrust bearing with a magnetic field detectorTORRINGTON CO·Filed 1989·Granted Oct 24, 1989·36 cites·7 claims
- 3576US11820727B1Capsaicinoid prodrug compounds and their use in treating medical conditionsCENTREXION THERAPEUTICS CORP·Filed 2022·Granted Nov 21, 2023·0 cites·20 claims
- 3676USRE41253EAntineoplastic combinationsWYETH CORP·Filed 2007·Granted Apr 20, 2010·2 cites·32 claims
- 3775US11230548B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2020·Granted Jan 25, 2022·0 cites·4 claims
- 3874US10189855B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2017·Granted Jan 29, 2019·0 cites·14 claims
- 3971US12037414B2Processes for preparing pharmaceutically relevant peptidesSTEALTH BIOTHERAPEUTICS INC·Filed 2020·Granted Jul 16, 2024·0 cites·1 claims
- 4070US2019382413A1Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2018·Application pending·0 cites
- 4169US10080733B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2017·Granted Sep 25, 2018·0 cites·4 claims
- 4268US10117846B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2017·Granted Nov 6, 2018·0 cites·10 claims
- 4368US7157589B2One step process for the preparation of anticonvulsant derivativesORTHO MCNEIL PHARM INC·Filed 2004·Granted Jan 2, 2007·4 cites·29 claims
- 4466US10005790B2Process for the synthesis of substituted morphinansALKERMES PHARMA IRELAND LTD·Filed 2014·Granted Jun 26, 2018·0 cites·8 claims
- 4562US2016137660A1Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2015·Application pending·0 cites
- 4661US7227037B2Process for the synthesis of N-nacyl-2-amino-4-alkoxy-5-nitrobenzoic acidsWYETH CORP·Filed 2003·Granted Jun 5, 2007·2 cites·2 claims
- 4760US6933388B2Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolonesWYETH CORP·Filed 2004·Granted Aug 23, 2005·1 cites·34 claims
- 4859US10155772B2Process for the synthesis of substituted morphinansALKERMES PHARMA IRELAND LTD·Filed 2018·Granted Dec 18, 2018·0 cites·17 claims
- 4956US10633415B2Processes for preparing pharmaceutically relevant peptidesSTEALTH BIOTHERAPEUTICS CORP·Filed 2016·Granted Apr 28, 2020·0 cites·14 claims
- 5056US7294740B2Process for the synthesis of N-acyl-2-amino-4-alkoxy-5-nitrobenzoic acidsWYETH CORP·Filed 2007·Granted Nov 13, 2007·0 cites·12 claims
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Scott Duncan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →